Search Results - "Alvarez‐Baron, Elena"
-
1
The burden of epilepsy and unmet need in people with focal seizures
Published in Brain and behavior (01-09-2022)“…Background Epilepsy is one of the most common neurological conditions worldwide. As a chronic condition, epilepsy imposes a significant burden on people with…”
Get full text
Journal Article -
2
Differential mRNA expression patterns of the synaptotagmin gene family in the rodent brain
Published in Journal of comparative neurology (1911) (01-02-2009)“…Synaptotagmins are a large family of membrane‐trafficking proteins. They are evolutionarily conserved and have 15 members in rodents and humans…”
Get full text
Journal Article -
3
Autoantibodies to Munc18, cerebral plasma cells and B-lymphocytes in Rasmussen encephalitis
Published in Epilepsy research (01-07-2008)“…Summary Rasmussen encephalitis (RE) is a rare form of severe unihemispheric epilepsy established to be an autoimmune disease. Here we demonstrate the presence…”
Get full text
Journal Article -
4
RIM proteins and their role in synapse function
Published in Biological chemistry (01-06-2010)“…Active zones are specialized areas of the plasma membrane in the presynaptic nerve terminal that mediate neurotransmitter release and synaptic plasticity. The…”
Get more information
Journal Article -
5
147 Long-term cenobamate retention in people with focal onset seizures: pooled data from open-label studies
Published in Journal of neurology, neurosurgery and psychiatry (01-06-2022)“…PurposeMost people with epilepsy receive chronic, long-term treatment with ≥1 anti-seizure medication. Retention rates provide can act as a proxy measure for…”
Get full text
Journal Article -
6
157 Efficacy of adjunctive cenobamate: post-hoc analysis in patients grouped by concomitant anti-epileptic drug type
Published in Journal of neurology, neurosurgery and psychiatry (01-06-2022)“…PurposeThere has been little success with polytherapy for patients with drug-resistant epilepsy. The need for optimizing AED combinations is high. Cenobamate…”
Get full text
Journal Article -
7
163 Long-term safety of adjunctive cenobamate in patients with uncontrolled focal seizures
Published in Journal of neurology, neurosurgery and psychiatry (01-06-2022)“…PurposeResults from two double-blind, placebo-controlled studies demonstrated that adjunctive ceno- bamate significantly reduced the frequency of seizures vs…”
Get full text
Journal Article -
8
Mapping analysis to predict SF-6D utilities from health outcomes in people with focal epilepsy
Published in The European journal of health economics (01-09-2023)“…Background Focal-onset seizures (FOS) are commonly experienced by people with epilepsy and have a significant impact on quality of life (QoL). This study aimed…”
Get full text
Journal Article -
9
Cénobamate, un nouveau médicament anti-épileptique doté d’un double mécanisme d’action unique et complémentaire
Published in Revue neurologique (01-09-2020)“…Le cénobamate est un nouveau médicament anti-épileptique récemment approuvé par la FDA. Or, jusqu’à présent, son mécanisme d’action n’a été décrit que…”
Get full text
Journal Article -
10
RIM3γ and RIM4γ are key regulators of neuronal arborization
Published in The Journal of neuroscience (09-01-2013)“…The large isoforms of the Rab3 interacting molecule (RIM) family, RIM1α/β and RIM2α/β, have been shown to be centrally involved in mediating presynaptic active…”
Get full text
Journal Article -
11
Identifying key unmet needs and value drivers in the treatment of focal-onset seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through Multi-Criteria Decision Analysis (MCDA)
Published in Epilepsy & behavior (01-09-2021)“…•Drug-resistant epilepsy is considered a severe condition.•Drug-resistant epilepsy affects approximately 40% of epileptic patients.•Drug-resistant epilepsy…”
Get full text
Journal Article -
12
Number needed to treat and associated cost analysis of cenobamate versus third-generation anti-seizure medications for the treatment of focal-onset seizures in patients with drug-resistant epilepsy in Spain
Published in Epilepsy & behavior (01-02-2023)“…•Cenobamate represents the most efficacy ASM vs third-generation ASMs.•Cenobamate at DDD represents the most efficient ASM vs third-generation…”
Get full text
Journal Article -
13
Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA)
Published in Epilepsy & behavior (01-08-2023)“…•Drug-resistant epilepsy (DRE) is considered a severe condition.•DRE is associated with important burden for patients and the healthcare system.•Cenobamate…”
Get full text
Journal Article -
14
The specific anti-hostility effect of lurasidone in patients with an acute exacerbation of schizophrenia: results of pooled post hoc analyses in adolescents and adults
Published in International clinical psychopharmacology (22-07-2024)“…Symptoms of hostility in patients during acute exacerbations of schizophrenia have been associated with aggressive behavior. Data suggest that some…”
Get full text
Journal Article